'Real-life' gait analysis can guide MS treatment, researchers say
Use of a body-worn sensor to track movements could help grade a person’s severity of multiple sclerosis, guiding treatment, research has shown.
At-home gait measurement, with varied walking conditions and frequent changes of direction, could help grade the severity of multiple sclerosis (MS), a study has shown.
The researchers analysed gait characteristics in 14 people with moderate-to-severe ambulatory impairment caused by MS, first in the laboratory setting and then with a body-worn sensor over one week of ‘everyday living’.
The team found that the accuracy of the wearable sensor was comparable to a recent study in healthy individuals and was not affected by disability severity. The measurements taken in short walking periods (<50 consecutive steps) during daily life were the most informative to determine the level of disability and effect of interventions.
Writing in PLoS One (1 May 2018), the authors concluded: “The study provides a robust approach for the quantification of recognised clinically relevant outcomes and an innovative perspective in the study of real-life walking.”
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204972
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00Buy now